Table 6.
Fatigue (n = 17) |
No fatigue (n = 25) |
Healthy controls (n = 13) |
Sign. | ||||
---|---|---|---|---|---|---|---|
T1 |
T2 |
T1 |
T2 |
T1 |
T2 |
||
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | ||
BDI | 7.29 (7.32) | 6.41 (7.75) | 4.84 (4.64) | 2.8 (2.48) | 3.23 (4.44) | 1.92 (2.22) | |
EDSS | 4.56 (1.27) | 3.91 (1.28) | 3.04 (1.95) | 3.39 (1.83) | N/A | N/A | a, b |
MSFC | −0.18 (0.44) | −0.07 (0.34) | −0.06 (0.57) | 0.07 (0.62) | 0.47 (0.41) | 0.57 (0.34) | |
PASAT | 42.50 (12.60) | 47.13 (8.52) | 45.20 (11.10) | 47.28 (10.70) | 47.77 (10.32) | 51.54 (11.23) | |
Lesion load | 3.71 (2.57) | 3.80 (2.61) | 7.07 (15.77) | 7.09 (15.99) | 0.03 (0.08) | 0.07 (0.18) | |
TBV | 1201.01 (109.05) | 1178.80 (103.78) | 1219.12 (130.77) | 1209.59 (128.02) | 1280.9 (72.55) | 1275.3 (75.80) | |
BPF | 0.81 (0.04) | 0.80 (0.04) | 0.81 (0.04) | 0.81 (0.04) | 0.85 (0.15) | 0.84 (0.02) | |
Lateral ventricles | 40.92 (24.68) | 41.92 (25.03) | 36.00 (30.87) | 36.65 (31.25) | 16.78 (6.43) | 16.88 (6.80) | |
Volume of third and fourth ventricle | 4.22 (1.47) | 4.31 (1.44) | 3.43 (1.46) | 3.61 (1.43) | 2.72 (1.27) | 2.85 (1.31) | |
CCI | 0.326 (0.067) | 0.352 (0.067) | 0.329 (0.068) | 0.368 (0.071) | 0.43 (0.05) | 0.45 (0.04) | b |
Axial and radial diffusivity of the corpus callosum | 0.0013 (0.0001) | 0.0013 (0.0001) | 0.0013 (0.0001) | 0.0013 (0.0002) | 0.0012 (0.0000) | 0.0012 (0.0001) |
BDI, Beck’s Depression Inventory; BPF, brain parenchymal fraction; CCI, corpus callosum index; EDSS, Expanded Disability Status Scale; FSS, Fatigue Severity Scale; FSMC, Multiple Sclerosis Functional Composite; MS, multiple sclerosis; PASAT, Paced Auditory Serial Addition Test; TBV, total brain volume.
Significant difference (p < 0.05) for a: main factor GROUP, b: significant main factor TIME, and c: significant interaction group × time.